Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Ketoacidosis | 1 | 2018 | 6 | 0.610 |
Why?
|
| Blindness | 1 | 2018 | 34 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 123 | 0.530 |
Why?
|
| Iliac Aneurysm | 1 | 2015 | 8 | 0.500 |
Why?
|
| Hematuria | 1 | 2015 | 10 | 0.500 |
Why?
|
| Iliac Artery | 1 | 2015 | 19 | 0.490 |
Why?
|
| Arteriovenous Malformations | 1 | 2015 | 16 | 0.490 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2015 | 9 | 0.480 |
Why?
|
| Chylothorax | 1 | 2015 | 3 | 0.480 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 54 | 0.470 |
Why?
|
| Urinary Bladder | 1 | 2015 | 119 | 0.460 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 126 | 0.450 |
Why?
|
| Lung Diseases | 1 | 2013 | 43 | 0.410 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2013 | 216 | 0.350 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2007 | 2 | 0.280 |
Why?
|
| Middle Aged | 9 | 2018 | 7138 | 0.270 |
Why?
|
| Mesentery | 1 | 2006 | 9 | 0.270 |
Why?
|
| Digoxin | 1 | 2006 | 8 | 0.260 |
Why?
|
| Histoplasma | 1 | 2006 | 6 | 0.260 |
Why?
|
| Myxoma | 1 | 2006 | 6 | 0.260 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 22 | 0.260 |
Why?
|
| Histoplasmosis | 1 | 2006 | 10 | 0.260 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 17 | 0.260 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 28 | 0.260 |
Why?
|
| Ischemia | 1 | 2006 | 83 | 0.250 |
Why?
|
| Male | 11 | 2018 | 13492 | 0.210 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 356 | 0.210 |
Why?
|
| Humans | 15 | 2018 | 28099 | 0.200 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 371 | 0.200 |
Why?
|
| Aged | 6 | 2017 | 5400 | 0.180 |
Why?
|
| Cryosurgery | 1 | 2017 | 19 | 0.130 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2017 | 19 | 0.130 |
Why?
|
| Bronchoscopy | 1 | 2017 | 34 | 0.130 |
Why?
|
| Female | 7 | 2017 | 15157 | 0.130 |
Why?
|
| Syndrome | 1 | 2015 | 78 | 0.120 |
Why?
|
| Pleurodesis | 1 | 2015 | 3 | 0.120 |
Why?
|
| Pleural Effusion | 1 | 2015 | 14 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 69 | 0.120 |
Why?
|
| Radiography | 1 | 2015 | 202 | 0.120 |
Why?
|
| Disease Management | 1 | 2015 | 88 | 0.120 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 76 | 0.120 |
Why?
|
| Triglycerides | 1 | 2015 | 121 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2015 | 90 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2014 | 24 | 0.110 |
Why?
|
| Immune System | 1 | 2013 | 29 | 0.110 |
Why?
|
| Spirometry | 1 | 2013 | 10 | 0.110 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2013 | 16 | 0.110 |
Why?
|
| Bronchodilator Agents | 1 | 2013 | 15 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 54 | 0.100 |
Why?
|
| ADAMTS13 Protein | 1 | 2013 | 126 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 103 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2015 | 612 | 0.100 |
Why?
|
| Sleep | 1 | 2013 | 108 | 0.100 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 65 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 65 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 165 | 0.100 |
Why?
|
| Incidence | 1 | 2013 | 562 | 0.090 |
Why?
|
| Antioxidants | 1 | 2014 | 223 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 387 | 0.090 |
Why?
|
| Oklahoma | 1 | 2013 | 1007 | 0.080 |
Why?
|
| Inflammation | 1 | 2013 | 636 | 0.080 |
Why?
|
| Tomography, Emission-Computed | 1 | 2007 | 6 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2007 | 24 | 0.070 |
Why?
|
| Troponin | 1 | 2007 | 2 | 0.070 |
Why?
|
| Protein C | 1 | 2007 | 38 | 0.070 |
Why?
|
| Child | 1 | 2013 | 2242 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 99 | 0.070 |
Why?
|
| Sepsis | 1 | 2007 | 84 | 0.070 |
Why?
|
| Quinolizines | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ondansetron | 1 | 2006 | 1 | 0.060 |
Why?
|
| Granisetron | 1 | 2006 | 1 | 0.060 |
Why?
|
| Quinuclidines | 1 | 2006 | 10 | 0.060 |
Why?
|
| Antiemetics | 1 | 2006 | 4 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2006 | 14 | 0.060 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2006 | 2 | 0.060 |
Why?
|
| Nausea | 1 | 2006 | 17 | 0.060 |
Why?
|
| Vomiting | 1 | 2006 | 14 | 0.060 |
Why?
|
| Organoplatinum Compounds | 1 | 2006 | 24 | 0.060 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2006 | 4 | 0.060 |
Why?
|
| Young Adult | 1 | 2013 | 2733 | 0.060 |
Why?
|
| Echocardiography | 1 | 2006 | 108 | 0.060 |
Why?
|
| Adolescent | 1 | 2013 | 3122 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 521 | 0.060 |
Why?
|
| Sarcoma, Myeloid | 1 | 2005 | 7 | 0.060 |
Why?
|
| Indoles | 1 | 2006 | 99 | 0.060 |
Why?
|
| Heart Atria | 1 | 2006 | 175 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2005 | 75 | 0.060 |
Why?
|
| Heart Failure | 1 | 2006 | 249 | 0.050 |
Why?
|
| Adult | 2 | 2013 | 7740 | 0.050 |
Why?
|
| Time Factors | 1 | 2006 | 1593 | 0.050 |
Why?
|
| Prognosis | 2 | 2013 | 803 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2017 | 34 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 2546 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 241 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2021 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2007 | 2379 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 2081 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2007 | 50 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 288 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 413 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 56 | 0.020 |
Why?
|
| Peroxidase | 1 | 2005 | 39 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 463 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 10423 | 0.010 |
Why?
|